SCHEMBL6078092

SCHEMBL6078092

COC(=O)[C@@H](CC1CC1)NC(=O)OC(C)(C)C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 3/20 0.63
CTSK P43235 3/20 0.63
AAK1 Q2M2I8 2/20 0.50
KMT2A Q03164 1/20 0.45
NFKB1 P19838 2/20 0.45
NFKB2 Q00653 2/20 0.45
RELA Q04206 2/20 0.45
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.42
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
CTSL P07711 1/20 0.41
CA12 O43570 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7084925 1.00 CTSS (0.63) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL14151599 1.00 CTSS (0.63) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL16228708 0.94 CTSS (0.57) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL1863337 0.94 CTSS (0.57) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL12632054 0.94 CTSS (0.57) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL3609923 0.94 CTSS (0.57) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL28283598 0.94 CTSS (0.57) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL19385461 0.94 CTSK (0.63) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL29414317 0.94 CTSK (0.60) CTSSCTSKAAK1KMT2ANFKB1
SCHEMBL4576713 0.94 CTSK (0.63) CTSSCTSKAAK1KMT2ANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7144899-B2 Thrombin inhibitors MERCK & CO., INC. (US) 2006-12-05 US disclosed
WO-2004032834-A2 THROMBIN INHIBITORS MERCK & CO., INC. (US) 2004-04-22 WO disclosed
US-20040073025-A1 Thrombin inhibitors MERCK SHARP & DOHME CORP. 2004-04-15 US disclosed
WO-2002064559-A2 THROMBIN INHIBITORS MERCK & CO., INC. (US) 2002-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073025-A1 Thrombin inhibitors F2, F11, F10 CTSS 283/4885CTSK 781/4885AAK1 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.